THTX Berita Valas
Theratechnologies Files SBLA For Trogarzo Intramuscular Method Of Administration With FDA
Biopharmaceutical company Theratechnologies Inc. (THTX, TH.TO) announced Tuesday the filing of a supplemental Biologics License Application (sBLA) for an intramuscular (IM) method of administration for the maintenance dose of Trogarzo (ibalizumab-uiyk) to the U.S. Food and Drug Administration (FDA) for review.
RTTNews
|
1002 hari yang lalu
Theratechnologies Files SBLA For F8 Formulation Of Tesamorelin To FDA
Biopharmaceutical company Theratechnologies Inc. (THTX, TH.TO) announced it has filed a supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin to the U.S. Food and Drug Administration (FDA) for review.
RTTNews
|
1101 hari yang lalu
